453 related articles for article (PubMed ID: 12542520)
1. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts.
Park JE; Lenter MC; Zimmermann RN; Garin-Chesa P; Old LJ; Rettig WJ
J Biol Chem; 1999 Dec; 274(51):36505-12. PubMed ID: 10593948
[TBL] [Abstract][Full Text] [Related]
3. Expression of stromal cell markers in distinct compartments of human skin cancers.
Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P
J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310
[TBL] [Abstract][Full Text] [Related]
4. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
5. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Scanlan MJ; Raj BK; Calvo B; Garin-Chesa P; Sanz-Moncasi MP; Healey JH; Old LJ; Rettig WJ
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5657-61. PubMed ID: 7911242
[TBL] [Abstract][Full Text] [Related]
7. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
Welt S; Divgi CR; Scott AM; Garin-Chesa P; Finn RD; Graham M; Carswell EA; Cohen A; Larson SM; Old LJ
J Clin Oncol; 1994 Jun; 12(6):1193-203. PubMed ID: 8201382
[TBL] [Abstract][Full Text] [Related]
8. Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers.
Niedermeyer J; Scanlan MJ; Garin-Chesa P; Daiber C; Fiebig HH; Old LJ; Rettig WJ; Schnapp A
Int J Cancer; 1997 May; 71(3):383-9. PubMed ID: 9139873
[TBL] [Abstract][Full Text] [Related]
9. bcl-2 protein expression in melanocytic neoplasms of the skin.
Ramsay JA; From L; Kahn HJ
Mod Pathol; 1995 Feb; 8(2):150-4. PubMed ID: 7777475
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA
Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
[TBL] [Abstract][Full Text] [Related]
11. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.
Ramirez-Montagut T; Blachere NE; Sviderskaya EV; Bennett DC; Rettig WJ; Garin-Chesa P; Houghton AN
Oncogene; 2004 Jul; 23(32):5435-46. PubMed ID: 15133496
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
[TBL] [Abstract][Full Text] [Related]
13. UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins-TGF-β1-FAP-α.
Wäster P; Orfanidis K; Eriksson I; Rosdahl I; Seifert O; Öllinger K
Br J Cancer; 2017 Aug; 117(4):535-544. PubMed ID: 28697174
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet exposure of melanoma cells induces fibroblast activation protein-α in fibroblasts: Implications for melanoma invasion.
Wäster P; Rosdahl I; Gilmore BF; Seifert O
Int J Oncol; 2011 Jul; 39(1):193-202. PubMed ID: 21491083
[TBL] [Abstract][Full Text] [Related]
15. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
18. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
19. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
20. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]